About Steriscience Specialties Private Limited
Data last updated:
Steriscience Specialties Private Limited is a private limited company based in Thane, Maharashtra, India, a subsidiary of Tenshi Pharmaceuticals Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2020PTC424881. Its GSTIN is 29ABECS3133N1ZZ (Karnataka).
The company has an authorised share capital of ₹55 Lakh and a paid-up capital of ₹2.09 Lakh. It was formerly known as Steriscience Pharma Private Limited. It is led by directors Chandrappa Seetharamaiah and Chhitiz Saraogi.
Its last annual general meeting (AGM) was held on 20 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Sector 17, Thane, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.53 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹2,229.65 Cr and EBITDA of -₹10.26 Cr (EBITDA margin -107.6%). Revenue has declined at a compounded annual rate (CAGR) of 49% over three years.
The company has about 770 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary and 1 joint venture.
The company is associated with 2 brands: Steriscience and Tenshi Life Sciences. As per MCA filings, the company has open charges of ₹308 Cr and satisfied charges of ₹225 Cr on record. Court records list 1 case involving the company, including 1 filed by the company. The company has 5 deals on record (2 funding rounds, 2 rights issues, 1 acquisition), with disclosed funding of ₹70.15 Cr; the latest was in November 2022. Its 5 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 3 smaller; the largest is Tulsi Amrit Private Limited with revenue of ₹9.54 Cr. The company has 8 MSME Form 1 returns on record between 2022 and 2024, listing 495 overdue payments to 83 micro and small suppliers.
For more details, the company can be reached via its website tenshi.co.in.
Company details
CIN history
Steriscience Specialties has one previous CIN (Corporate Identification Number): U24304KA2020PTC137884. The current CIN is U24304MH2020PTC424881, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24304MH2020PTC424881 | Current |
| U24304KA2020PTC137884 | Previous |
Contact details
Steriscience Specialties Private Limited's registered office is in Thane, Maharashtra. Its website is tenshi.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address201 Devavrata Sector 17, Vashi Navi Mumbai, Thane, Maharashtra, India – 400703
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Steriscience Specialties Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Steriscience Specialties operates two associated brands: Steriscience and Tenshi Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality sterile injectable products. | steri-science.com | |
| Delivers advanced finished dosage pharmaceuticals using global infrastructure and quality systems. | tenshi.co.in |
Business activity
The main business activity of Steriscience Specialties is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Steriscience Specialties Private Limited, buy the company report.
Financials of Steriscience Specialties Private Limited
FY 2024 filings availableSteriscience Specialties Private Limited reported revenue of ₹9.53 Cr (up 238% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 238% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 49%. EBITDA rose 52% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹10.26 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2,229.65 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -107.6% | ||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Steriscience Specialties Private Limited, buy the company report.
Board of directors of Steriscience Specialties Private Limited
Steriscience Specialties has 2 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandrappa Seetharamaiah | Director | 02 Jun 2021 | 5 Years 5 Months | Current |
| Chhitiz Saraogi Also directs: Brooks Steriscience Limited | Director | 17 May 2024 | 2 Years 5 Months | Current |
Peer comparison
Steriscience Specialties Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tulsi Amrit Private Limited | ₹9.54 Cr (FY 2024) | 8.0% | Indore, Madhya Pradesh, India | |||
| Integrin Healthcare Private Limited | ₹9.54 Cr (FY 2025) | 105.0% | Hyderabad, Telangana, India | |||
| Steriscience Specialties Private Limitedthis company | ₹9.53 Cr (FY 2025) | ₹2,229.65 Cr | 238.0% | 770 | Thane, Maharashtra, India | |
| Willmark Pharmaceuticals Private Limited | ₹9.49 Cr (FY 2025) | -7.0% | Punjab, India | |||
| Health Secure (India) Private Limited | ₹9.46 Cr (FY 2021) | 0.0% | Nashik, Maharashtra, India | |||
| Adnova Healthcare Private Limited | ₹9.45 Cr (FY 2025) | 27.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Steriscience Specialties Private Limited, buy the company report.
Auditor
Steriscience Specialties Private Limited is audited by Deloitte Haskins & Sells for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Deloitte Haskins & Sells | FY 2023 | 008072S |
Shareholding
The shareholding of Steriscience Specialties Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Steriscience Specialties Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Dec 2023 | 100841657 | Others | ₹50 Cr | Open | |
| 02 Mar 2022 | 100553871 | Hdfc Bank Limited | ₹22 Cr | Open | |
| 02 Mar 2022 | 100551927 | Hdfc Bank Limited | ₹235 Cr | Open | |
| 05 Apr 2021 | 100470781 | Others | ₹1 Cr | Open | |
| 23 Jan 2024 | 100863005 | Others | ₹25 Cr | Satisfied |
To see the full charge records of Steriscience Specialties Private Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
Steriscience Specialties Private Limited has 5 deals on record (2 funding rounds, 2 rights issues, 1 acquisition), with disclosed funding of ₹70.15 Cr; the latest was in November 2022.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2022 | Rights issue | ₹24.02 Cr | Investors: TPG Capital India, Tenshi Life Sciences Private Limited |
| May 2021 | Funding round | ₹40.15 Cr | Investors: TPG Capital India |
| Feb 2021 | Rights issue | ₹6.2 Cr | Investors: Tenshi Life Sciences Private Limited |
| Nov 2020 | Funding round | ₹30 Cr | Investors: Tenshi Life Sciences Private Limited |
| Sep 2020 | Acquisition | ₹51.04 Cr | Buyer: Tenshi Life Sciences Private Limited Seller: Karuna Business Solutions LLP |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Steriscience Specialties Private Limited has 1 court case on record: 1 filed by Steriscience Specialties. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Court case (Com.A.A.) | Filed by the company against Eastern Silk Industries Limited | Disposed |
To see the full case history of Steriscience Specialties Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Steriscience Specialties Private Limited has 8 MSME Form 1 returns on record between 2022 and 2024, listing 495 overdue payments to 83 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 83)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Juniper Life Sciences Private Limited | |||
| an individual supplier | |||
| Angle Concepts LLP | |||
| an individual supplier | |||
| Infosit Corporate Solutions |
To see the full MSME payment records of Steriscience Specialties Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Steriscience Specialties has 1 subsidiary company and 1 joint venture. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Steribrooks Penems Private Limited | U24232KA2020PTC135017 |
To see the full group structure of Steriscience Specialties Private Limited, buy the company report.
Employees & EPFO
Steriscience Specialties Private Limited has a workforce of 770 employees on its EPFO records as of Mar 31, 2024, across 1 active EPFO establishment.
GST
Steriscience Specialties has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29ABECS3133N1ZZ | Karnataka | Active | 10 Nov 2020 |
To see the full GST registrations and return filing status of Steriscience Specialties Private Limited, buy the company report.
Recent activity
Steriscience Specialties Private Limited has 13 board changes on record since 2020: 3 appointments and 10 cessations. The latest: Bhushan Sudhir Bopardikar ceased to be Additional Director on 19 Sep 2024.
18 earlier events are in the company report.
Frequently asked questions
Steriscience Specialties is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 August 2020 (6+ years old) and is registered under CIN U24304MH2020PTC424881.
Steriscience Specialties has 2 current directors:
- Chandrappa Seetharamaiah - Director
- Chhitiz Saraogi - Director
The latest financial statements of Steriscience Specialties on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 20 September 2024. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Steriscience Specialties is 29ABECS3133N1ZZ, registered in Karnataka.
The CIN (Corporate Identification Number) of Steriscience Specialties is U24304MH2020PTC424881. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Steriscience Specialties has 1 court case on record: 1 filed by the company.
Steriscience Specialties was incorporated on 29 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Steriscience Specialties has 5 deals on record (2 funding rounds, 2 rights issues, 1 acquisition), with disclosed funding of ₹70.15 Cr; the latest was in November 2022.
The peers of Steriscience Specialties by revenue are Tulsi Amrit Private Limited, Integrin Healthcare Private Limited, Willmark Pharmaceuticals Private Limited, Health Secure (India) Private Limited, Adnova Healthcare Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bhushan Sudhir Bopardikar ceased to be Additional Director on 19 Sep 2024. Chhitiz Saraogi ceased to be Additional Director on 19 Sep 2024. Chhitiz Saraogi was appointed as Director on 17 May 2024. Steriscience Specialties has 13 board changes on record in total.
Steriscience Specialties has 8 MSME Form 1 returns on record between 2022 and 2024, listing 495 overdue payments to 83 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Steriscience Specialties can be reached through the website tenshi.co.in. Its registered office is in Thane, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
